Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD study of coadministration of allopurinol or febuxostat with inosine in healthy Japanese males
jRCTs031190115Completed
- Sponsor
- StaGen
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of allopurinol, febuxostat and inosine in Parkinson's disease (PD) (2 arms), sponsored by StaGen. Primary endpoint: Blood hypoxanthine concentration. Started Oct 2019; status: completed.
02
Drugs
allopurinolfebuxostatinosine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on jRCTs031190115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031190115.